CeleCor Therapeutics

Funding and NIH signals

• SEC Form D raise Raised $11.86M (Form D filed Jul 9, 2026). SEC Form D 0001705381-26-000006 (Jul 9, 2026)
  Evidence (1 event)

  • Jul 9, 2026 · SEC Form D 0001705381-26-000006
    Name of Issuer: CeleCor Therapeutics, Inc.; CIK: 1705381; Address: Del Mar, CA; Submission type: D; Filing date: 2026-07-09; Industry Group: Pharmaceuticals; Date of First Sale: 2026-06-09; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 15000000; Total Amount Sold: 11856325; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals